{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:52:52Z","timestamp":1777517572250,"version":"3.51.4"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,11,1]]},"DOI":"10.1093\/ndt\/15.11.1801","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:52:07Z","timestamp":1027723927000},"page":"1801-1807","source":"Crossref","is-referenced-by-count":55,"title":["Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis"],"prefix":"10.1093","volume":"15","author":[{"given":"Linda","family":"Zarif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwini R.","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Sedor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Schelling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,11]]},"reference":[{"key":"key\n\t\t\t\t20180110063221_R1","doi-asserted-by":"crossref","unstructured":"Cooper RS, Rotimi CN, Ward R. The puzzle of hypertension in African\u2010Americans. Sci Am1999; 280: 56\u201363","DOI":"10.1038\/scientificamerican0299-56"},{"key":"key\n\t\t\t\t20180110063221_R2","unstructured":"US Renal Data System. USRDS 1999 Annual Data Report The National Institutes of Health, NIDDK, Bethesda: 1999"},{"key":"key\n\t\t\t\t20180110063221_R3","doi-asserted-by":"crossref","unstructured":"Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA1992; 268: 3085\u20133091","DOI":"10.1001\/jama.268.21.3085"},{"key":"key\n\t\t\t\t20180110063221_R4","doi-asserted-by":"crossref","unstructured":"Hebert LA, Kusek JW, Greene T et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997; 30: 428\u2013435","DOI":"10.1161\/01.HYP.30.3.428"},{"key":"key\n\t\t\t\t20180110063221_R5","doi-asserted-by":"crossref","unstructured":"Klag MJ, Whelton PK, Randall BL et al. End\u2010stage renal disease in African\u2010American and white men. 16\u2010year MRFIT findings. JAMA1997; 277: 1293\u20131298","DOI":"10.1001\/jama.277.16.1293"},{"key":"key\n\t\t\t\t20180110063221_R6","doi-asserted-by":"crossref","unstructured":"Ferguson R, Grim CE, Opgenorth TJ. A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol1988; 41: 1189\u20131196","DOI":"10.1016\/0895-4356(88)90023-6"},{"key":"key\n\t\t\t\t20180110063221_R7","doi-asserted-by":"crossref","unstructured":"Freedman BI, Spray BJ, Tuttle AB, Buckalew VM, Jr. The familial risk of end\u2010stage renal disease in African Americans. Am J Kidney Dis1993; 21: 387\u2013393","DOI":"10.1016\/S0272-6386(12)80266-6"},{"key":"key\n\t\t\t\t20180110063221_R8","doi-asserted-by":"crossref","unstructured":"Freedman BI, Soucie JM, McClellan WM. Family history of end\u2010stage renal disease among incident dialysis patients. J Am Soc Nephrol1997; 8: 1942\u20131945","DOI":"10.1681\/ASN.V8121942"},{"key":"key\n\t\t\t\t20180110063221_R9","doi-asserted-by":"crossref","unstructured":"Tracy RE. Blood pressure related separately to parenchymal fibrosis and vasculopathy of the kidney. Am J Kidney Dis1992; 20: 124\u2013131","DOI":"10.1016\/S0272-6386(12)80539-7"},{"key":"key\n\t\t\t\t20180110063221_R10","doi-asserted-by":"crossref","unstructured":"Levy SB, Talner LB, Coel MN, Holle R, Stone RA. Renal vasculature in essential hypertension: racial differences. Ann Intern Med1978; 88: 12\u201316","DOI":"10.7326\/0003-4819-88-1-12"},{"key":"key\n\t\t\t\t20180110063221_R11","doi-asserted-by":"crossref","unstructured":"Frohlich ED, Messerli FH, Dunn FG et al. Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab1984; 10: 173\u2013177","DOI":"10.1007\/978-1-4613-3897-0_12"},{"key":"key\n\t\t\t\t20180110063221_R12","doi-asserted-by":"crossref","unstructured":"Ghosh S, Schork NJ. Genetic analysis of NIDDM. The study of quantitative traits. Diabetes1996; 45: 1\u201314","DOI":"10.2337\/diab.45.1.1"},{"key":"key\n\t\t\t\t20180110063221_R13","doi-asserted-by":"crossref","unstructured":"Freedman BI, Iskander SS, Buckalew VMJ, Burkart JM, Appel RG. Renal biopsy findings in presumed hypertensive nephrosclerosis. Am J Nephrol1994; 14: 90\u201394","DOI":"10.1159\/000168695"},{"key":"key\n\t\t\t\t20180110063221_R14","doi-asserted-by":"crossref","unstructured":"Zucchelli P, Zuccala A. Can we accurately diagnose nephrosclerosis? Nephrol Dial Transplant1995; 10 [Suppl 6]: 2\u20135","DOI":"10.1093\/ndt\/10.supp6.2"},{"key":"key\n\t\t\t\t20180110063221_R15","doi-asserted-by":"crossref","unstructured":"D'Amico G. Comparability of the different registries on renal replacement therapy. Am J Kidney Dis1995; 25: 113\u2013118","DOI":"10.1016\/0272-6386(95)90637-1"},{"key":"key\n\t\t\t\t20180110063221_R16","doi-asserted-by":"crossref","unstructured":"Schelling JR, Zarif L, Sehgal A, Iyengar S, Sedor JR. Genetic susceptibility to end\u2010stage renal disease. Curr Opin Nephrol Hypertens1999; 8: 465\u2013472","DOI":"10.1097\/00041552-199907000-00011"},{"key":"key\n\t\t\t\t20180110063221_R17","unstructured":"Iyengar S, Covic A, Olson J et al. Is early\u2010onset ESRD in African\u2010Americans mediated by genetic factors? J Am Soc Nephrol1999; 10: 76A"},{"key":"key\n\t\t\t\t20180110063221_R18","doi-asserted-by":"crossref","unstructured":"Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end\u2010stage renal disease due to hypertension. Am J Kidney Dis1994; 23: 655\u2013660","DOI":"10.1016\/S0272-6386(12)70275-5"},{"key":"key\n\t\t\t\t20180110063221_R19","doi-asserted-by":"crossref","unstructured":"Fogo A, Breyer JA, Smith MC et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int1997; 51: 244\u2013252","DOI":"10.1038\/ki.1997.29"},{"key":"key\n\t\t\t\t20180110063221_R20","doi-asserted-by":"crossref","unstructured":"Bleyer AJ, Chen R, D'Agostino RB Jr, Appel RG. Clinical correlates of hypertensive end\u2010stage renal disease. Am J Kidney Dis1998; 31: 28\u201334","DOI":"10.1053\/ajkd.1998.v31.pm9428448"},{"key":"key\n\t\t\t\t20180110063221_R21","doi-asserted-by":"crossref","unstructured":"Luke RG. Hypertensive nephrosclerosis: pathogenesis and prevalence. Nephrol Dial Transplant1999; 14: 2271\u20132278","DOI":"10.1093\/ndt\/14.10.2271"},{"key":"key\n\t\t\t\t20180110063221_R22","doi-asserted-by":"crossref","unstructured":"Shulman NB, Ford CE, Hall WD et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow\u2010up program. The Hypertension Detection and Follow\u2010up Program Cooperative Group. Hypertension1989; 13: I80\u2013I93","DOI":"10.1161\/01.HYP.13.5_Suppl.I80"},{"key":"key\n\t\t\t\t20180110063221_R23","doi-asserted-by":"crossref","unstructured":"Cusi D, Tripodi G, Casari G et al. Genetics of renal damage in primary hypertension. Am J Kidney Dis1993; 21: 2\u20139","DOI":"10.1016\/0272-6386(93)70092-D"},{"key":"key\n\t\t\t\t20180110063221_R24","doi-asserted-by":"crossref","unstructured":"De Leeuw PW. Renal function in the elderly: results from the European Working Party on High Blood Pressure in the Elderly trial. Am J Med1991; 90: 45S\u201349S","DOI":"10.1016\/0002-9343(91)90436-2"},{"key":"key\n\t\t\t\t20180110063221_R25","doi-asserted-by":"crossref","unstructured":"Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int1984; 26: 861\u2013868","DOI":"10.1038\/ki.1984.229"},{"key":"key\n\t\t\t\t20180110063221_R26","doi-asserted-by":"crossref","unstructured":"Perneger TV, Whelton PK, Klag MJ, Rossiter KA. Diagnosis of hypertensive end\u2010stage renal disease: effect of patient's race. Am J Epidemiol1995; 141: 10\u201315","DOI":"10.1093\/oxfordjournals.aje.a117338"},{"key":"key\n\t\t\t\t20180110063221_R27","unstructured":"Innes A, Johnston PA, Morgan AG, Davison AM, Burden RP. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy. Q J Med1993; 86: 271\u2013275"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/15\/11\/1801\/23366538\/151801.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T17:37:37Z","timestamp":1621273057000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/15\/11\/1801\/1918535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,1]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2000,11]]},"published-print":{"date-parts":[[2000,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/15.11.1801","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,11]]},"published":{"date-parts":[[2000,11,1]]}}}